Improving Access and Use of Medicines through Private Sector Initiatives: A case for an Essential Medicines Franchise in Ghana Eghan Kwesi, Mensah D, Idun.

Slides:



Advertisements
Similar presentations
THE CHALLENGES & OPORTUNITIES OF ACCESS TO MEDICINES IN AFRICA Dr Pascoal MOCUMBI, orig Mozambique,High Representative EDCTP ABRASCO/WFPHA.
Advertisements

UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
Overview of the medicine prices and availability survey methodology Presentation template for adaptation and use in medicine prices and availability survey.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Implementing NICE guidance
Promoting Rational Drug Use in the Community Monitoring and evaluation.
REDUCING MATERNAL AND NEONATAL MORTALITY IN MOZAMBIQUE THE CHALLENGE IN THE NEW MILLENIUM.
RATIONAL USE OF INJECTION: An Integrated Tool For Monitoring Injection Prescription in the Kingdom of CAMBODIA Dr Sok Srun Department of Hospitals, MoH.
Inaugural Conference of the African Health Economics and Policy Association (AfHEA) Accra - Ghana, 10th - 12th March 2009 Patent medicines vendors a resource.
1. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus 2. Department of Clinical.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Antibiotic Policy in Ghana; the way forward
Improving Access to ACTs Through Licensed Chemical Sellers in Ghana David Ofori-Adjei 1, Sylvester Segbaya 2, Kwadwo Koram 1, Kwame Adogboba 3, and Nana.
Pakistan.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Essential Medicines Programmes Sudan now Essential Medicines Programmes Sudan now.
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
Repositioning Family Planning in West Africa Repositionnement de la Planification Familiale en Afrique de l’Ouest Sponsored by: U.S. Agency for International.
Management of Uterotonic medicines for use in the prevention of post-partum hemorrhage Grace Adeya, SPS/MSH.
Use of an Indicator-Based System for Assessing, Monitoring, and Improving Pharmacy Practice Authors: Lates, J. (1); Sumbi, V. (2); Phulu, B. (1); Rushubiza,
MDG Needs Assessment Training Workshop May 9-12, 2005 Health Module.
Agenda  Motivation and Overview (using Education as an example)  Discussion by Selected Intervention Area  Energy Services.
Cambodia1. 2 Cambodia Assessment Ung Phirun Chroeng Sokhan.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
UNDP RBA MDG-Based National Development Planning Workshop Health Module Chandrika Bahadur UN Millennium Project February 27-March 3, 2006.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
Primer on Monitoring and Evaluation. The 3 Pillars of Monitoring and Evaluation  Identifying the Performance Indicators  Collecting information using.
EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.
Problem Statement: In Kenya, despite the development of national standard treatment guidelines (STGs) for the management of acute respiratory infections.
Improving Access and Use of Medicines through Private Sector Initiatives: A case for an Essential Medicines Franchise in Ghana.
Strategies for Enhancing Access to Medicines Overview of Potential Strategies for Improving Access and Use David Lee.
Improving Uncomplicated Malaria Case Management by Drug Shops through Accreditation and Regulation AZIZ MAIJA, MSH.
CPM Programs1. 2 Center for Pharmaceutical Management Programs James Rankin.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Roadmap to Achieve RBM Targets September 2009 – December 2010 Ghana.
Bad intentions - good policies: Who wins? Case exercise and role play on drug counterfeiting in an LDC context World Bank Case Exercise – all names and.
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Vision and Goal Vision Option -1 = 6 Option-2=4 Goal Vision -1= 10.
Do Village Revolving Funds Improve Access and Rational Use of Drugs in Laos? Bigdeli M 1 Ketsouvannasane B 2 Shuey DA 1 1.WHO, Laos 2.Ministry of Health,
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
Improving Access to Essential Medicines through Public-Private Initiatives: The Case of the Catholic Pharmaceutical Service in Ghana.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
ABSTRACT THE CHALLENGE OF INTEGRATING A RDU TRAINING MODEL INTO THE REALITY OF A HEALTH SYSTEM CONTEXT Problem Statement: The Dar es Salaam Urban Health.
ICIUM 2011 Can Accredited Drug Dispensing Outlets (ADDO) Accomplishments be Sustained in Tanzania.
MONITORING MEDICINE AVAILABILITY AND PRICES IN UGANDA By Denis Kibira HEPS Uganda.
Maggie Montgomery Water and Health Conference, Chapel Hill Oct 2015 International Network on Household Water Treatment and Safe Storage Regional Workshops.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
Expanding Regulated Private Sector Medicines Access - Experiences with Accredited Drug Dispensing Outlets Romuald Mbwasi, PhD.
Making BFHI a Standard of Care in Health Care will Improve Implementation of 10 Steps in Health Facilities: Tanzanian Hypothesis Presented at IA Conference,
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Medicines use in children under 5 years primary care in developing and transitional countries Results from studies reported between Kathleen.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Zambia’s Country Experiences
Malaria - the facts are on the cards.
East African Drug Seller Initiative Uganda Sensitization Meeting
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
Descriptive Analysis of Performance-Based Financing Education Project in Burundi Victoria Ryan World Bank Group May 16, 2017.
Kandeke C, Chibuta C, Banda D
Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan
Assessing and Monitoring Maternal Health Commodity Security
Accredited Drug Dispensing Outlets (ADDOs): Improving Access to Quality Drugs and Services in Rural and Peri-urban Areas with Few.
Zambia’s Country Experiences
The Case of the Catholic Pharmaceutical Service in Ghana
Increasing access to family planning commodities through accredited drug shops: the Uganda experience Aziz Maija MSH Uganda October 12, 2016.
Presentation transcript:

Improving Access and Use of Medicines through Private Sector Initiatives: A case for an Essential Medicines Franchise in Ghana Eghan Kwesi, Mensah D, Idun J, Staley,R. Marsden,A. Arhinful,K. Ofori- Adjei,D. Dodoo A.

ABSTRACT

Background Demographics source: 2000 census data Population: 19 Million Sex Male: 49.5% Female: 50.5% LocalityRural: 56.2 % Urban: 43.8% Growth Rate: 2.7% Population Density: 79.3 pers/sq.km PHARMACIES 1028 CHEMICAL SELLER 7000 Maternal Mortality Rate: 214 Life Expectancy: 58 HIV Prevalence: 3.8% Ghana is a tropical country situated in the West Coast of Africa and located between latitudes 4 ˚ & 11 ˚ North of the equator Economic Indicators GNI per capita $340 Inflation Rate % Per Capita Health Spending $8

Background The Strategies for Enhancing Access to Medicines (SEAM) Program was established in 2002 with a trinity of country-level public-private initiatives to improve access to essential medicines and commodities. The three (3) components are: Establishing a franchise of chemical seller shops that provide essential medicines and health supplies; Improving pharmaceutical supply and promoting more appropriate use of medicines in the Mission sector (Catholic) of Ghana; and Strengthening the Pharmacy Council’s capacity to regulate chemical seller shops in Ghana

Problem Statement Almost sixty –six (66%) 1 of Ghanaians visit the Licensed Chemical Seller ( LCS) as their first point of call when accessing health care services. Yet most have little or no healthcare background. Additionally LCS are small individually run operations with high overheads. This had lead to Poor quality service provision by LCS Resource- heavy and inefficient operations leading to high prices. Additionally there exist a low level of regulatory and supervisory visit from the authorities

Objective Questions The problems raises two questions Can we enhance the access to medicines and improve rational use of medicines by private sector initiatives? Specifically, can the above objectives be achieved through an essential medicines franchise in a sub-Saharan African country with limited resources?

Intervention An Essential Medicines Franchise network – branded as CAREshops was set up in the Volta Region as a pilot The Volta Region, with its 1.6 m people, is served by only 621(8.8%) and 17(1.5%) of the National 7000 LCS and 1028 Pharmacies 2 A Structured modular training programme was implemented for the accredited CAREshop Managers. This was over a 10 week period with 2 week breaks in between modules. A group purchasing program and a logistically sound distribution network was established by GSMFEL CAREshop Franchisor Regular monthly supervisory and mentoring visits were conducted with the CAREshop Periodic impact assessment of programwas is undertaken through - Review of Records, - Drug Availability and Affordability surveys, - Mystery shopping and Field observations. 1. MSH baseline Survey 2000 Ghana 2. Pharmacy Council 2002.

Methodology & Outcome Measures Based on the training needs assessment a Pre and post training knowledge assessment was conducted. Data was collected on the availability of tracer drugs in CAREshops Level of stocking and supply of insecticide treated nets– a key indicator in relation to contemporary initiatives in malaria control were and prevention in CAREshops were measured

Results 1- Improvement in knowledge of CAREshop operators The number of LCS obtaining a 60% basic score before and after training was measured This tool will be reapplied in Oct 2004and Jan 2005

RESULT 2 Tracer Drug Availability CAREshop Franchise Tracer Drugs Allowed to Stock VR N=66All Regions Franchise Jan 2004 N= 79 Acetylsalicylic acid tabs 300mg100.0%99.6% 100% Aluminium Hydroxide 500mg89.4%80.4% 98% Amodiaquine 200mg22.7%20.0% 34% Chloramphenicol Eye Ointment27.3%30.8% 45% Chloroquine Tab 150mg97.0%94.4% 100% Chlorpheniramine 4mg Tab78.8%68.8% 100% Condoms97.0%94.4% 100% Ferrous Sulphate/Fumarate 200mg Tab62.1%56.4% 98% Ibuprofen 200mg Tab86.4%76.4% 100% Oral Rehydration Salt89.4%92.4% 100% Paracetamol tab 500mg100.0%96.8% 100% Secure86.4%84.0% 90% Sulfadoxine/Pyrimethamine tab 500mg/25mg68.2%63.2% 100% Treated Bednets3.0%1.6% 7% Average % for Tracer Drugs % Availability of 15 tracer drugs (franchise to non franchise :70% to 83% Availability of ITN (franchise to non franchise : 3% to 7%

Discussion Measurable improvement noted in medicine supply and use by CAREshops especially through the established group purchasing and distribution system Increase in knowledge and practice level of Franchise Chemical Sellers observed Observations of the current interventions also show that working with the private sector requires an understanding of the motivations of private sector providers These motivations include, but in most cases are not limited to – financial benefits –image enhancement –increased skill and competence leading to increased commitment to proper sale and supply of medicines

Conclusion Private sector initiatives can improve access to medicines Franchising of essential medicine suppliers provides opportunity for training, improvement in service delivery and cost of reduction in supply chain Regular monitoring and an understanding of the motivation private sector providers is essential for success

Next Steps …..  Conclude and Implement Access dimensions for evaluation  Evaluation to measure the CAREshop Program impact on * Quality of Dispensing (communication and counseling) * Quality of Stocked products * Appropriateness of Recommendations * Affordabilty and availabilty of essential medicines * Acceptabilty /satisfaction with the CAREshop outlets  Assess the enablers and constraints of the franchise program implementation Post intervention regional assessment planned for October 2004 and March 2005